Analytical Data
-
基因名
UTS2
- Application
-
别名
PRO1068; U-II; UCN2; UII; Urotensin 2 preproProtein isoform a; Urotensin 2 preproProtein isoform b; Urotensin II; Urotensin-2; UTS2; UTS2_HUMAN; UTSII
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O95399
-
表达区间
114-124 aa
-
氨基酸序列
ETPDCFW KYCV
-
分子量
14.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
UTS2 (Urotensin II) is a peptide that plays a crucial role in various physiological and pathological processes, including cardiovascular regulation, renal function, and neuroprotection. Discovered as a potent vasoconstrictor, UTS2 is involved in several signaling pathways that affect blood pressure and cardiac contractility. Recent studies highlight its potential implications in diseases such as heart failure, hypertension, and metabolic disorders. The recombinant expression of UTS2 allows researchers to investigate its functional properties, receptor interactions, and biological effects in detail. Moreover, understanding UTS2's mechanism of action could lead to the development of novel therapeutic strategies targeting related disorders. The advancement in recombinant protein technologies has facilitated the production of UTS2 variants for biochemical and pharmaceutical applications, making it essential to explore its structure-function relationship. This ongoing research contributes to a broader understanding of urotensin's role in human health and disease, paving the way for innovative approaches in treating conditions associated with dysregulated UTS2 signaling.
